CN101983682A - Medicament for treating female climacteric metancholia - Google Patents
Medicament for treating female climacteric metancholia Download PDFInfo
- Publication number
- CN101983682A CN101983682A CN2010105085898A CN201010508589A CN101983682A CN 101983682 A CN101983682 A CN 101983682A CN 2010105085898 A CN2010105085898 A CN 2010105085898A CN 201010508589 A CN201010508589 A CN 201010508589A CN 101983682 A CN101983682 A CN 101983682A
- Authority
- CN
- China
- Prior art keywords
- grams
- restrains
- medicine
- medicament
- ganoderma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 23
- 241000222336 Ganoderma Species 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 4
- 208000011580 syndromic disease Diseases 0.000 claims description 17
- 239000012467 final product Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 230000000694 effects Effects 0.000 abstract description 11
- 210000003734 kidney Anatomy 0.000 abstract description 5
- 231100000331 toxic Toxicity 0.000 abstract description 5
- 230000002588 toxic effect Effects 0.000 abstract description 5
- 241000605447 Anemarrhena Species 0.000 abstract 1
- 241000213006 Angelica dahurica Species 0.000 abstract 1
- 244000084791 Curculigo orchioides Species 0.000 abstract 1
- 241000893536 Epimedium Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 241000972672 Phellodendron Species 0.000 abstract 1
- 229930191283 anemarrhena Natural products 0.000 abstract 1
- 235000018905 epimedium Nutrition 0.000 abstract 1
- 208000024891 symptom Diseases 0.000 description 5
- 238000000034 method Methods 0.000 description 4
- 230000001105 regulatory effect Effects 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000000988 bone and bone Anatomy 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 238000005728 strengthening Methods 0.000 description 3
- 206010054196 Affect lability Diseases 0.000 description 2
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000000994 depressogenic effect Effects 0.000 description 2
- 229940079593 drug Drugs 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 206010022437 insomnia Diseases 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 206010010774 Constipation Diseases 0.000 description 1
- 206010016825 Flushing Diseases 0.000 description 1
- 206010040943 Skin Ulcer Diseases 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000002651 drug therapy Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 230000002996 emotional effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 208000007357 hyperpituitarism Diseases 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 230000005906 menstruation Effects 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- 231100000019 skin ulcer Toxicity 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a medicament for treating female climacteric metancholia. The component proportion of the preparation is as follows: aerial parts of epimedium 10g, Curculigo orchioides 10g, morinda officinalis 10g, phellodendron 10g, anemarrhena 10g, Chinese angelica 10g and ganoderma 10g. The accuracy of the ratio of the fixed dosages is plus or minus 10% of the above components. The medicament has the advantages of invigorating kidney qi and coordinating yin and yang. The above medicament has a safe and obvious effect on treating female climacteric metancholia and is free of any toxic or side effect.
Description
Technical field
The present invention relates to a kind of Chinese medicine medicine, specifically a kind of medicine of female dimacteric syndrome.
Background technology
Climacteric syndrome is a series of symptoms that caused by decrease in estrogen, climacteric women is because hypo-ovaria, hyperpituitarism, the promoting sexual gland hormone of supersecretion, cause the autonomic nervous dysfunction, thereby the different symptom of a series of degree appears, as menstruation variation, flushed face, cardiopalmus, insomnia, weak, depressed, worry too much, emotional instability, emotional, attention is difficult to concentrate etc., the medication effect of some treatment female dimacteric syndromes is undesirable, and some contains toxic side effect, increases the weight of people's the state of an illness.
Summary of the invention
In order to solve the unfavorable problem of curative effect of medication of treatment female dimacteric syndrome, the invention provides the medicine of female dimacteric syndrome, this medicine the kidney invigorating gas, regulating YIN and YANG, the treatment female dimacteric syndrome is evident in efficacy, takes safe without toxic side effect.
Concrete proportioning of the present invention: Herba Epimedii 10 gram, Rhizoma Curculiginis 10 grams, Radix Morindae Officinalis 10 grams, Cortex Phellodendri 10 grams, the Rhizoma Anemarrhenae 10 grams, Radix Angelicae Sinensis 10 grams, Ganoderma 10 grams, the degree of accuracy of the dose of this medicine be each medicine ± 10%.
Pharmacology of the present invention is: Herba Epimedii: kidney-replenishing, bone and muscle strengthening, wind-damp dispelling; Rhizoma Curculiginis: reinforcing the kidney and supporting YANG, benefiting essence-blood, bone and muscle strengthening and promoting the circulation of blood detumescence; Radix Morindae Officinalis: kidney-replenishing, strengthening bone and muscle, wind-damp dispelling; Cortex Phellodendri: heat clearing and damp drying, pathogenic fire purging remove steams, detoxifies and treat skin ulcer; The Rhizoma Anemarrhenae: clearing away heat-fire, promote the production of body fluid and moisturize; Radix Angelicae Sinensis: enrich blood invigorate blood circulation, menstruction regulating and pain relieving, loosening bowel to relieve constipation.
Preparation method of the present invention is: get Herba Epimedii 10 gram, Rhizoma Curculiginis 10 grams, Radix Morindae Officinalis 10 grams, Cortex Phellodendri 10 grams, the Rhizoma Anemarrhenae 10 grams, Radix Angelicae Sinensis 10 grams, Ganoderma 10 grams and be mixed into sieve, the clear water sieve dashes, and pulls oven dry out, pulverizes, and machine is made ball and got final product.
Instructions of taking: one day twice, each 5-6 gram, ten days is a course of treatment.
The invention has the beneficial effects as follows: the medicine the kidney invigorating gas of this female dimacteric syndrome, regulating YIN and YANG, the treatment female dimacteric syndrome is evident in efficacy, takes safe without toxic side effect.
Specific embodiment
Through over 2 years, to the clinical practice of 100 routine female dimacteric syndrome sufferers, obtained curative effect preferably, its cure rate reaches more than 95%, and total effective rate reaches 98%, and details are as follows for relevant clinical treatment situation:
1. patient profile: select projects such as medical history, the state of an illness, age and original therapy method.
2. patient originates: with general hospital patient and professional OH patient.
3. case is gone into the group standard, and according to climacteric syndrome patient's clinical manifestation and pathological characters branch, the age is not limit, the medicine and the therapeutic modality of various other treatment climacteric syndromes of stopping using before the treatment.
4. compound method: get Herba Epimedii 10 grams, Rhizoma Curculiginis 10 grams, Radix Morindae Officinalis 10 grams, Cortex Phellodendri 10 grams, the Rhizoma Anemarrhenae 10 grams, Radix Angelicae Sinensis 10 grams, Ganoderma 10 grams and be mixed into sieve, the clear water sieve dashes, and pulls oven dry out, pulverizes, and machine is made ball and got final product.
5. administrated method: one day twice, each 5-6 gram, ten days is a course of treatment.
6. efficacy evaluation:
1. recovery from illness: cardiopalmus, insomnia, weak, depressed, worry too much, transference cure such as emotional instability.
2. remarkable: the climacteric syndrome symptom obviously reduces.
3. effective: that recurrence is not arranged after the healing.
4. invalid: change not quite before and after the treatment, or once taking a turn for the better, after return to symptom before the treatment again.
7. efficacy analysis:
1. according to going into the group standard, we treat female patient 100 examples altogether
2. age group: 40～45 years old 25 example, 45～50 years old 50 example, 51～57 years old 25 example.
3. prepare the dose scheme for first kind: Herba Epimedii 10 restrains, Rhizoma Curculiginis 10 restrains, Radix Morindae Officinalis 10 restrains, Cortex Phellodendri 10 restrains, the Rhizoma Anemarrhenae 10 restrains, Radix Angelicae Sinensis 10 restrains, Ganoderma 10 restrains.
The efficacy analysis of this scheme, administration time are 1～3 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 50 examples | 39 | 7 | 3 | 1 |
| Moderate patient's 35 examples | 24 | 6 | 4 | 1 |
| Severe patient 15 examples | 7 | 4 | 3 | 1 |
The scheme of second kind of preparation dose: Herba Epimedii 11 grams, Rhizoma Curculiginis 11 grams, Radix Morindae Officinalis 11 grams, Cortex Phellodendri 11 grams, the Rhizoma Anemarrhenae 11 grams, Radix Angelicae Sinensis 11 grams, Ganoderma 11 grams.
The efficacy analysis of this scheme, administration time are 1～3 course of treatment.
| Patient's type | Recovery from illness | Significantly | Effectively | Invalid |
| Patients with mild 45 examples | 30 | 11 | 2 | 1 |
| Moderate patient's 40 examples | 28 | 7 | 4 | 1 |
| Severe patient 15 examples | 8 | 3 | 3 | 1 |
By Drug therapy female dimacteric syndrome of the present invention, received satisfied curative effect.The symptom of this disease is a lot, and this clinical experiment is divided into " slightly ", " moderate " and " seriously " several types according to clinical characters, and this clinical experiment is to carry out jointly at general hospital and special outpatient clinic.Before this group case treatment, during most of patients was carried out, the treatment of doctor trained in Western medicine mode, but all do not obtain curative effect preferably, in taking the process of medicine of the present invention, cut out other medicine.
The medicine the kidney invigorating gas of this female dimacteric syndrome, regulating YIN and YANG, evident in efficacy, take safe without toxic side effect.
Claims (2)
1. the medicine of a female dimacteric syndrome, it is characterized in that: concrete proportioning of the present invention is Herba Epimedii 10 gram, Rhizoma Curculiginis 10 grams, Radix Morindae Officinalis 10 grams, Cortex Phellodendri 10 grams, the Rhizoma Anemarrhenae 10 grams, Radix Angelicae Sinensis 10 grams, Ganoderma 10 grams, the degree of accuracy of this dose ratio be each medicine ± 10%.
2. the medicine of a female dimacteric syndrome, it is characterized in that: Herba Epimedii 10 restrains preparation method of the present invention in order to get, Rhizoma Curculiginis 10 restrains, Radix Morindae Officinalis 10 restrains, Cortex Phellodendri 10 restrains, the Rhizoma Anemarrhenae 10 restrains, Radix Angelicae Sinensis 10 restrains, Ganoderma 10 restrains and is mixed into sieve, the clear water sieve dashes, pull oven dry out, pulverize, machine is made ball and is got final product.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105085898A CN101983682A (en) | 2010-10-12 | 2010-10-12 | Medicament for treating female climacteric metancholia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2010105085898A CN101983682A (en) | 2010-10-12 | 2010-10-12 | Medicament for treating female climacteric metancholia |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN101983682A true CN101983682A (en) | 2011-03-09 |
Family
ID=43640847
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2010105085898A Pending CN101983682A (en) | 2010-10-12 | 2010-10-12 | Medicament for treating female climacteric metancholia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN101983682A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106334073A (en) * | 2016-10-28 | 2017-01-18 | 刘红霞 | Traditional Chinese medicine for treating climacteric hypertension |
| CN106353446A (en) * | 2016-08-12 | 2017-01-25 | 上海黄海制药有限责任公司 | Identification and content measuring method of climacteric-syndrome-soothing granules |
| CN108452159A (en) * | 2018-06-19 | 2018-08-28 | 安徽医科大学 | Application of the ERXIAN TANG in preparing antidepressant |
-
2010
- 2010-10-12 CN CN2010105085898A patent/CN101983682A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106353446A (en) * | 2016-08-12 | 2017-01-25 | 上海黄海制药有限责任公司 | Identification and content measuring method of climacteric-syndrome-soothing granules |
| CN106334073A (en) * | 2016-10-28 | 2017-01-18 | 刘红霞 | Traditional Chinese medicine for treating climacteric hypertension |
| CN108452159A (en) * | 2018-06-19 | 2018-08-28 | 安徽医科大学 | Application of the ERXIAN TANG in preparing antidepressant |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102362947B (en) | Chinese medicine for treating cough | |
| CN101961449B (en) | Traditional Chinese medicine for treating tinea corporis | |
| CN101983644A (en) | Medicament for treating sequelae of apoplexy | |
| CN101983717A (en) | Traditional Chinese medicine for treating migraine | |
| CN101983682A (en) | Medicament for treating female climacteric metancholia | |
| CN101983672A (en) | Medicament for treating cramp | |
| CN102784332A (en) | Medicine for treating angiitis | |
| CN107412640B (en) | External ointment for assisting acupuncture and moxibustion physiotherapy | |
| CN101983652A (en) | Traditional Chinese medicine for treating scapulohumeral periarthritis | |
| CN102078472A (en) | Medicament for treating verruca wart | |
| CN102430018B (en) | Medicinal composition for treating rheumatic and rheumatoid arthritis | |
| CN104147261B (en) | A kind of Chinese medicine preparation for treating rheumatic arthritis | |
| CN101961455A (en) | Traditional Chinese medicine for treating chronic colitis disease | |
| CN102078432A (en) | Medicament for treating skin itch | |
| CN101983650A (en) | Medicament for treating dermatitis aestivale | |
| CN101979036A (en) | Medicinal liquor for treating rheumatic arthritis | |
| CN102488832B (en) | Traditional Chinese medicine composition for treating mastitis | |
| CN104189273A (en) | Traditional Chinese medicine used for treating thrombophlebitis | |
| CN101983676A (en) | Medicament for treating gynecological blood stasis and qi stagnation | |
| CN101983712A (en) | Novel medicament for treating coronary heart disease | |
| CN101983719A (en) | Novel medicament for treating lung cancer | |
| CN103690833B (en) | A kind of Chinese medicine for the treatment of rheumatic arthritis | |
| CN102908585B (en) | One treats sciatica Chinese medicine | |
| CN101983645A (en) | Medicament for treating acute appendicitis | |
| CN106039236A (en) | Traditional Chinese medicine preparation for treating bone cancer and improving immunity, and preparation method of traditional Chinese medicine preparation |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20110309 |